APO Research
Talk to an analyst

APO RESEARCH · REPORT

Albendazole Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Albendazole Tablets Market Outlook and Growth Opportunities 2026

27 December 2025216 pages

Choose your research edition.

Industry ResearchAlbendazole Tablets Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Albendazole Tablets Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Albendazole Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albendazole Tablets Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Albendazole Tablets Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Albendazole Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Albendazole Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Albendazole Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Albendazole Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Albendazole Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Albendazole Tablets market include Chongqing Kerui Pharmaceutical (Group) Co., Ltd., Zhejiang Anbet Pharmaceutical Co., Ltd., Sichuan Tiande Pharmaceutical Co., Ltd., Shanghai Xinya Pharmaceutical Minhang Co., Ltd., Sancai Shiqi Pharmaceutical Co., Ltd., Ningxia Qiyuan National Pharmaceutical Co., Ltd., Longhui Pharmaceutical Co., Ltd., Huazhong Pharmaceutical Co., Ltd. and Hubei Ruihua Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Albendazole Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Albendazole Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Albendazole Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Albendazole Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Albendazole Tablets Segment by Company

Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Zhejiang Anbet Pharmaceutical Co., Ltd.

Sichuan Tiande Pharmaceutical Co., Ltd.

Shanghai Xinya Pharmaceutical Minhang Co., Ltd.

Sancai Shiqi Pharmaceutical Co., Ltd.

Ningxia Qiyuan National Pharmaceutical Co., Ltd.

Longhui Pharmaceutical Co., Ltd.

Huazhong Pharmaceutical Co., Ltd.

Hubei Ruihua Pharmaceutical Co., Ltd.

Hubei Meibao Pharmaceutical Co., Ltd.

Hubei Kelun Pharmaceutical Co., Ltd.

Hubei Guangji Pharmaceutical Co., Ltd.

Henan Runhong Pharmaceutical Co., Ltd.

Hangzhou Minsheng Pharmaceutical Co., Ltd.

Guangzhou Kanghe Pharmaceutical Co., Ltd.

Anhui Shengying Pharmaceutical Co., Ltd.

Teva

Sequent Scientific

Salius Pharma

Lasa Supergenerics Limited

K.A. Malle Pharmaceuticals

GlaxoSmithKline

Fredun Pharmaceuticals Ltd

AdvaCare Pharma

Aden

Albendazole Tablets Segment by Type

0.1g

0.2g

Albendazole Tablets Segment by Application

For Veterinary Use

For Human Use

Albendazole Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Albendazole Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Albendazole Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Albendazole Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Albendazole Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albendazole Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albendazole Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albendazole Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Albendazole Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Albendazole Tablets industry.

Chapter 3: Detailed analysis of Albendazole Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Albendazole Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Albendazole Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Albendazole Tablets Industry Trends Table 2. Albendazole Tablets Industry Drivers Table 3. Albendazole Tablets Industry Opportunities and Challenges Table 4. Albendazole Tablets Industry Restraints Table 5. Global Albendazole Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Albendazole Tablets Revenue Share by Company (2021-2026) Table 7. Global Albendazole Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Albendazole Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Albendazole Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Albendazole Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Albendazole Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Albendazole Tablets Company, Product Type & Application Table 13. Global Albendazole Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Albendazole Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.1g Table 18. Significant Companies of 0.2g Table 19. Global Albendazole Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Albendazole Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Albendazole Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Albendazole Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Albendazole Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Albendazole Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Albendazole Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Albendazole Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Albendazole Tablets Sales Value Share by Type (2021-2026) Table 28. Global Albendazole Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of For Veterinary Use Table 30. Significant Companies of For Human Use Table 31. Global Albendazole Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Albendazole Tablets Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Albendazole Tablets Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Albendazole Tablets Sales Volume Share by Application (2021-2026) Table 35. Global Albendazole Tablets Sales Volume Share by Application (2027-2032) Table 36. Global Albendazole Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Albendazole Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Albendazole Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Albendazole Tablets Sales Value Share by Application (2021-2026) Table 40. Global Albendazole Tablets Sales Value Share by Application (2027-2032) Table 41. Global Albendazole Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Albendazole Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Albendazole Tablets Sales Market Share by Region (2021-2026) Table 44. Global Albendazole Tablets Sales by Region (2027-2032) & (K Units) Table 45. Global Albendazole Tablets Sales Market Share by Region (2027-2032) Table 46. Global Albendazole Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Albendazole Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Albendazole Tablets Sales Value Share by Region (2021-2026) Table 49. Global Albendazole Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Albendazole Tablets Sales Value Share by Region (2027-2032) Table 51. Global Albendazole Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Albendazole Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Albendazole Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Albendazole Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Albendazole Tablets Sales by Country (2021-2026) & (K Units) Table 56. Global Albendazole Tablets Sales Market Share by Country (2021-2026) Table 57. Global Albendazole Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Albendazole Tablets Sales Market Share by Country (2027-2032) Table 59. Global Albendazole Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Albendazole Tablets Sales Value Market Share by Country (2021-2026) Table 61. Global Albendazole Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Albendazole Tablets Sales Value Market Share by Country (2027-2032) Table 63. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information Table 64. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview Table 65. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Product Portfolio Table 67. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Development Table 68. Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information Table 69. Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview Table 70. Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 72. Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Development Table 73. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information Table 74. Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview Table 75. Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 77. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Development Table 78. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information Table 79. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview Table 80. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Product Portfolio Table 82. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Development Table 83. Sancai Shiqi Pharmaceutical Co., Ltd. Company Information Table 84. Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview Table 85. Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 87. Sancai Shiqi Pharmaceutical Co., Ltd. Recent Development Table 88. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Company Information Table 89. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Business Overview Table 90. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 92. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Recent Development Table 93. Longhui Pharmaceutical Co., Ltd. Company Information Table 94. Longhui Pharmaceutical Co., Ltd. Business Overview Table 95. Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 97. Longhui Pharmaceutical Co., Ltd. Recent Development Table 98. Huazhong Pharmaceutical Co., Ltd. Company Information Table 99. Huazhong Pharmaceutical Co., Ltd. Business Overview Table 100. Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 102. Huazhong Pharmaceutical Co., Ltd. Recent Development Table 103. Hubei Ruihua Pharmaceutical Co., Ltd. Company Information Table 104. Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview Table 105. Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 107. Hubei Ruihua Pharmaceutical Co., Ltd. Recent Development Table 108. Hubei Meibao Pharmaceutical Co., Ltd. Company Information Table 109. Hubei Meibao Pharmaceutical Co., Ltd. Business Overview Table 110. Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 112. Hubei Meibao Pharmaceutical Co., Ltd. Recent Development Table 113. Hubei Kelun Pharmaceutical Co., Ltd. Company Information Table 114. Hubei Kelun Pharmaceutical Co., Ltd. Business Overview Table 115. Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 117. Hubei Kelun Pharmaceutical Co., Ltd. Recent Development Table 118. Hubei Guangji Pharmaceutical Co., Ltd. Company Information Table 119. Hubei Guangji Pharmaceutical Co., Ltd. Business Overview Table 120. Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 122. Hubei Guangji Pharmaceutical Co., Ltd. Recent Development Table 123. Henan Runhong Pharmaceutical Co., Ltd. Company Information Table 124. Henan Runhong Pharmaceutical Co., Ltd. Business Overview Table 125. Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 127. Henan Runhong Pharmaceutical Co., Ltd. Recent Development Table 128. Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information Table 129. Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview Table 130. Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 132. Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Development Table 133. Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information Table 134. Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview Table 135. Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 137. Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Development Table 138. Anhui Shengying Pharmaceutical Co., Ltd. Company Information Table 139. Anhui Shengying Pharmaceutical Co., Ltd. Business Overview Table 140. Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 142. Anhui Shengying Pharmaceutical Co., Ltd. Recent Development Table 143. Teva Company Information Table 144. Teva Business Overview Table 145. Teva Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Teva Albendazole Tablets Product Portfolio Table 147. Teva Recent Development Table 148. Sequent Scientific Company Information Table 149. Sequent Scientific Business Overview Table 150. Sequent Scientific Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Sequent Scientific Albendazole Tablets Product Portfolio Table 152. Sequent Scientific Recent Development Table 153. Salius Pharma Company Information Table 154. Salius Pharma Business Overview Table 155. Salius Pharma Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Salius Pharma Albendazole Tablets Product Portfolio Table 157. Salius Pharma Recent Development Table 158. Lasa Supergenerics Limited Company Information Table 159. Lasa Supergenerics Limited Business Overview Table 160. Lasa Supergenerics Limited Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Lasa Supergenerics Limited Albendazole Tablets Product Portfolio Table 162. Lasa Supergenerics Limited Recent Development Table 163. K.A. Malle Pharmaceuticals Company Information Table 164. K.A. Malle Pharmaceuticals Business Overview Table 165. K.A. Malle Pharmaceuticals Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. K.A. Malle Pharmaceuticals Albendazole Tablets Product Portfolio Table 167. K.A. Malle Pharmaceuticals Recent Development Table 168. GlaxoSmithKline Company Information Table 169. GlaxoSmithKline Business Overview Table 170. GlaxoSmithKline Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. GlaxoSmithKline Albendazole Tablets Product Portfolio Table 172. GlaxoSmithKline Recent Development Table 173. Fredun Pharmaceuticals Ltd Company Information Table 174. Fredun Pharmaceuticals Ltd Business Overview Table 175. Fredun Pharmaceuticals Ltd Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. Fredun Pharmaceuticals Ltd Albendazole Tablets Product Portfolio Table 177. Fredun Pharmaceuticals Ltd Recent Development Table 178. AdvaCare Pharma Company Information Table 179. AdvaCare Pharma Business Overview Table 180. AdvaCare Pharma Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 181. AdvaCare Pharma Albendazole Tablets Product Portfolio Table 182. AdvaCare Pharma Recent Development Table 183. Aden Company Information Table 184. Aden Business Overview Table 185. Aden Albendazole Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 186. Aden Albendazole Tablets Product Portfolio Table 187. Aden Recent Development Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Albendazole Tablets Distributors List Table 191. Albendazole Tablets Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Albendazole Tablets Product Image Figure 2. Global Albendazole Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albendazole Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Albendazole Tablets Sales (2021-2032) & (K Units) Figure 5. Global Albendazole Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Albendazole Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.1g Image Figure 10. 0.2g Image Figure 11. Global Albendazole Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Albendazole Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Albendazole Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Albendazole Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Albendazole Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Albendazole Tablets Sales Value Share by Type (2021-2032) Figure 17. For Veterinary Use Image Figure 18. For Human Use Image Figure 19. Global Albendazole Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Albendazole Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Albendazole Tablets Sales Volume Share by Application (2021-2032) Figure 22. Global Albendazole Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Albendazole Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Albendazole Tablets Sales Value Share by Application (2021-2032) Figure 25. Global Albendazole Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Albendazole Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Albendazole Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Albendazole Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Albendazole Tablets Sales Value (2021-2032) & (US$ Million) Figure 30. North America Albendazole Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Albendazole Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Albendazole Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Albendazole Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Albendazole Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Albendazole Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. South America Albendazole Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Albendazole Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Albendazole Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Albendazole Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Albendazole Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Albendazole Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Albendazole Tablets Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Albendazole Tablets Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 0.1g
  • 0.2g
Applications
  • For Veterinary Use
  • For Human Use
Companies covered
  • Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  • Zhejiang Anbet Pharmaceutical Co., Ltd.
  • Sichuan Tiande Pharmaceutical Co., Ltd.
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  • Sancai Shiqi Pharmaceutical Co., Ltd.
  • Ningxia Qiyuan National Pharmaceutical Co., Ltd.
  • Longhui Pharmaceutical Co., Ltd.
  • Huazhong Pharmaceutical Co., Ltd.
  • Hubei Ruihua Pharmaceutical Co., Ltd.
  • Hubei Meibao Pharmaceutical Co., Ltd.
  • Hubei Kelun Pharmaceutical Co., Ltd.
  • Hubei Guangji Pharmaceutical Co., Ltd.
  • Henan Runhong Pharmaceutical Co., Ltd.
  • Hangzhou Minsheng Pharmaceutical Co., Ltd.
  • Guangzhou Kanghe Pharmaceutical Co., Ltd.
  • Anhui Shengying Pharmaceutical Co., Ltd.
  • Teva
  • Sequent Scientific
  • Salius Pharma
  • Lasa Supergenerics Limited
  • K.A. Malle Pharmaceuticals
  • GlaxoSmithKline
  • Fredun Pharmaceuticals Ltd
  • AdvaCare Pharma
  • Aden

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Albendazole Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Albendazole Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Albendazole Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Albendazole Tablets Market Dynamics
  1. 2.1 Albendazole Tablets Industry Trends
  2. 2.2 Albendazole Tablets Industry Drivers
  3. 2.3 Albendazole Tablets Industry Opportunities and Challenges
  4. 2.4 Albendazole Tablets Industry Restraints
3 Albendazole Tablets Market by Company
  1. 3.1 Global Albendazole Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Albendazole Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Albendazole Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Albendazole Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Albendazole Tablets Company Ranking (2024-2026)
  6. 3.6 Global Albendazole Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Albendazole Tablets Company Product Type and Application
  8. 3.8 Global Albendazole Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Albendazole Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Albendazole Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Albendazole Tablets Market by Type
  1. 4.1 Albendazole Tablets Type Introduction
  2. 4.1.1 0.1g
  3. 4.1.2 0.2g
  4. 4.2 Global Albendazole Tablets Sales Volume by Type
  5. 4.2.1 Global Albendazole Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Albendazole Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Albendazole Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Albendazole Tablets Sales Value by Type
  9. 4.3.1 Global Albendazole Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Albendazole Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Albendazole Tablets Sales Value Share by Type (2021-2032)
5 Albendazole Tablets Market by Application
  1. 5.1 Albendazole Tablets Application Introduction
  2. 5.1.1 For Veterinary Use
  3. 5.1.2 For Human Use
  4. 5.2 Global Albendazole Tablets Sales Volume by Application
  5. 5.2.1 Global Albendazole Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Albendazole Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Albendazole Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Albendazole Tablets Sales Value by Application
  9. 5.3.1 Global Albendazole Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Albendazole Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Albendazole Tablets Sales Value Share by Application (2021-2032)
6 Albendazole Tablets Regional Sales and Value Analysis
  1. 6.1 Global Albendazole Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Albendazole Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Albendazole Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Albendazole Tablets Sales by Region (2027-2032)
  5. 6.3 Global Albendazole Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Albendazole Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Albendazole Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Albendazole Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Albendazole Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Albendazole Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Albendazole Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Albendazole Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Albendazole Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Albendazole Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Albendazole Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Albendazole Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Albendazole Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Albendazole Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Albendazole Tablets Sales Value Share by Country, 2025 VS 2032
7 Albendazole Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Albendazole Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Albendazole Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Albendazole Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Albendazole Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Albendazole Tablets Sales by Country (2027-2032)
  6. 7.4 Global Albendazole Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Albendazole Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Albendazole Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Albendazole Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Albendazole Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Albendazole Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Albendazole Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Albendazole Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Albendazole Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Albendazole Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Albendazole Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Albendazole Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Albendazole Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Albendazole Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Albendazole Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Albendazole Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Albendazole Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Albendazole Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Albendazole Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Albendazole Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Albendazole Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Albendazole Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Albendazole Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Albendazole Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Albendazole Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Albendazole Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Albendazole Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Albendazole Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Albendazole Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Albendazole Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Albendazole Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Albendazole Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Albendazole Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  2. 8.1.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
  3. 8.1.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview
  4. 8.1.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Product Portfolio
  6. 8.1.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments
  7. 8.2 Zhejiang Anbet Pharmaceutical Co., Ltd.
  8. 8.2.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  12. 8.2.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Sichuan Tiande Pharmaceutical Co., Ltd.
  14. 8.3.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  18. 8.3.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  20. 8.4.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information
  21. 8.4.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview
  22. 8.4.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Product Portfolio
  24. 8.4.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Developments
  25. 8.5 Sancai Shiqi Pharmaceutical Co., Ltd.
  26. 8.5.1 Sancai Shiqi Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  30. 8.5.5 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Ningxia Qiyuan National Pharmaceutical Co., Ltd.
  32. 8.6.1 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  36. 8.6.5 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Longhui Pharmaceutical Co., Ltd.
  38. 8.7.1 Longhui Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Longhui Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  42. 8.7.5 Longhui Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Huazhong Pharmaceutical Co., Ltd.
  44. 8.8.1 Huazhong Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Huazhong Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  48. 8.8.5 Huazhong Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Hubei Ruihua Pharmaceutical Co., Ltd.
  50. 8.9.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  54. 8.9.5 Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Hubei Meibao Pharmaceutical Co., Ltd.
  56. 8.10.1 Hubei Meibao Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Hubei Meibao Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  60. 8.10.5 Hubei Meibao Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Hubei Kelun Pharmaceutical Co., Ltd.
  62. 8.11.1 Hubei Kelun Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Hubei Kelun Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  66. 8.11.5 Hubei Kelun Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Hubei Guangji Pharmaceutical Co., Ltd.
  68. 8.12.1 Hubei Guangji Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Hubei Guangji Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  72. 8.12.5 Hubei Guangji Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Henan Runhong Pharmaceutical Co., Ltd.
  74. 8.13.1 Henan Runhong Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Henan Runhong Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  78. 8.13.5 Henan Runhong Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Hangzhou Minsheng Pharmaceutical Co., Ltd.
  80. 8.14.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  84. 8.14.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Guangzhou Kanghe Pharmaceutical Co., Ltd.
  86. 8.15.1 Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  90. 8.15.5 Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Anhui Shengying Pharmaceutical Co., Ltd.
  92. 8.16.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Anhui Shengying Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  96. 8.16.5 Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Teva
  98. 8.17.1 Teva Company Information
  99. 8.17.2 Teva Business Overview
  100. 8.17.3 Teva Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Teva Albendazole Tablets Product Portfolio
  102. 8.17.5 Teva Recent Developments
  103. 8.18 Sequent Scientific
  104. 8.18.1 Sequent Scientific Company Information
  105. 8.18.2 Sequent Scientific Business Overview
  106. 8.18.3 Sequent Scientific Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Sequent Scientific Albendazole Tablets Product Portfolio
  108. 8.18.5 Sequent Scientific Recent Developments
  109. 8.19 Salius Pharma
  110. 8.19.1 Salius Pharma Company Information
  111. 8.19.2 Salius Pharma Business Overview
  112. 8.19.3 Salius Pharma Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Salius Pharma Albendazole Tablets Product Portfolio
  114. 8.19.5 Salius Pharma Recent Developments
  115. 8.20 Lasa Supergenerics Limited
  116. 8.20.1 Lasa Supergenerics Limited Company Information
  117. 8.20.2 Lasa Supergenerics Limited Business Overview
  118. 8.20.3 Lasa Supergenerics Limited Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Lasa Supergenerics Limited Albendazole Tablets Product Portfolio
  120. 8.20.5 Lasa Supergenerics Limited Recent Developments
  121. 8.21 K.A. Malle Pharmaceuticals
  122. 8.21.1 K.A. Malle Pharmaceuticals Company Information
  123. 8.21.2 K.A. Malle Pharmaceuticals Business Overview
  124. 8.21.3 K.A. Malle Pharmaceuticals Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 K.A. Malle Pharmaceuticals Albendazole Tablets Product Portfolio
  126. 8.21.5 K.A. Malle Pharmaceuticals Recent Developments
  127. 8.22 GlaxoSmithKline
  128. 8.22.1 GlaxoSmithKline Company Information
  129. 8.22.2 GlaxoSmithKline Business Overview
  130. 8.22.3 GlaxoSmithKline Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 GlaxoSmithKline Albendazole Tablets Product Portfolio
  132. 8.22.5 GlaxoSmithKline Recent Developments
  133. 8.23 Fredun Pharmaceuticals Ltd
  134. 8.23.1 Fredun Pharmaceuticals Ltd Company Information
  135. 8.23.2 Fredun Pharmaceuticals Ltd Business Overview
  136. 8.23.3 Fredun Pharmaceuticals Ltd Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Fredun Pharmaceuticals Ltd Albendazole Tablets Product Portfolio
  138. 8.23.5 Fredun Pharmaceuticals Ltd Recent Developments
  139. 8.24 AdvaCare Pharma
  140. 8.24.1 AdvaCare Pharma Company Information
  141. 8.24.2 AdvaCare Pharma Business Overview
  142. 8.24.3 AdvaCare Pharma Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 AdvaCare Pharma Albendazole Tablets Product Portfolio
  144. 8.24.5 AdvaCare Pharma Recent Developments
  145. 8.25 Aden
  146. 8.25.1 Aden Company Information
  147. 8.25.2 Aden Business Overview
  148. 8.25.3 Aden Albendazole Tablets Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Aden Albendazole Tablets Product Portfolio
  150. 8.25.5 Aden Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Albendazole Tablets Value Chain Analysis
  2. 9.1.1 Albendazole Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Albendazole Tablets Sales Mode & Process
  6. 9.2 Albendazole Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Albendazole Tablets Distributors
  9. 9.2.3 Albendazole Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst